Faricimab ophthalmic Disease Interactions
There is 1 disease interaction with faricimab ophthalmic.
Intravitreal injections (applies to faricimab ophthalmic) ocular infections
Major Potential Hazard, Moderate plausibility. Applicable conditions: Infectious Endophthalmitis, Infectious Optic Neuritis, Orbital Infection, Uveitis
Drugs requiring intravitreal administration (including aflibercept, faricimab, pegaptanib, and ranibizumab) are contraindicated in patients with active intraocular inflammation or ocular/periocular infections; intravitreal injections have been associated with endophthalmitis. Patients should be advised to seek immediate medical attention from an ophthalmologist if the eye becomes red, photosensitive, or painful, or if a change in vision occurs in the days following drug administration.
Switch to professional interaction data
Faricimab ophthalmic drug interactions
There are 20 drug interactions with faricimab ophthalmic.
Report options
More about faricimab ophthalmic
- faricimab ophthalmic consumer information
- Check interactions
- Compare alternatives
- Reviews (39)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
